Tani Jowy, Weng Hsing-Yu, Chen Hung-Ju, Chang Tsui-San, Sung Jia-Ying, Lin Cindy Shin-Yi
Department of Neurology, Wan Fang Hospital, Taipei Medical University, Taipei, Taiwan.
Ph.D. Program for Neural Regenerative Medicine, College of Medical Science and Technology, Taipei Medical University and National Health Research Institutes, Taipei, Taiwan.
Front Neurol. 2019 Jul 9;10:704. doi: 10.3389/fneur.2019.00704. eCollection 2019.
Abuse of nitrous oxide (NO) has an unusually high lifetime prevalence in developed countries and represents a serious concern worldwide. Myeloneuropathy following the inhalant abuse is commonly attributed to the disturbance of vitamin B12 metabolism, with severe motor deficits are often noted. The present study aims to elucidate its underlying pathophysiology. Eighteen patients with NO abuse or vitamin B12 deficiency were recruited. Comprehensive central and peripheral neuro-diagnostic tests were performed, including whole spine MRI, and thermal quantitative sensory testing (QST). Specifically, paired motor and sensory nerve excitability tests were performed in order to obtain a complete picture of the sensorimotor axonal damage. The mean duration of NO exposure for the NO abuse patients was 17.13 ± 7.23 months. MRI revealed T2 hyperintensity in 87.5% of the NO abuse patients and 50% of the vitamin B12 deficiency patients. In NO abuse patients, the motor nerve excitability test showed decreased in peak response (7.08 ± 0.87 mV, = 0.05), increased latency (7.09 ± 0.28 ms, < 0.01), increased superexcitability (-32.95 ± 1.74%, < 0.05), and decreased accommodation to depolarizing current [TEd (40-60 ms) 56.53 ± 0.70%, < 0.05]; the sensory test showed only decreased peak response (30.54 ± 5.98 μV, < 0.05). Meanwhile, motor test in vitamin B12 deficiency patients showed only decreased accommodation to depolarizing current [TEd (40-60 ms) 55.72 ± 1.60%, < 0.01]; the sensory test showed decreased peak response (25.86 ± 3.44 μV, < 0.05) increased superexcitability (-28.58 ± 3.71%, < 0.001), increased subexcitability (8.31 ± 1.64%, < 0.05), and decreased accommodation to depolarizing current [TEd (peak) 67.31 ± 3.35%, < 0.001]. Compared to vitamin B12 deficiency, NO abuse patients showed prominent motor superexcitability changes and less prominent sensory superexcitability changes, hinting a unique pathological process different from that of vitamin B12 deficiency. NO abuse might cause axonal dysfunction not only by blocking methionine metabolism but also by toxicity affecting the paranodal region.
在发达国家,一氧化二氮(NO)滥用的终生患病率异常高,这是一个全球范围内的严重问题。吸入性滥用后发生的脊髓神经病通常归因于维生素B12代谢紊乱,常伴有严重的运动功能障碍。本研究旨在阐明其潜在的病理生理学机制。招募了18名一氧化二氮滥用或维生素B12缺乏的患者。进行了全面的中枢和外周神经诊断测试,包括全脊柱MRI和热定量感觉测试(QST)。具体而言,进行了配对的运动和感觉神经兴奋性测试,以全面了解感觉运动轴突损伤情况。一氧化二氮滥用患者的一氧化二氮暴露平均持续时间为17.13±7.23个月。MRI显示,87.5%的一氧化二氮滥用患者和50%的维生素B12缺乏患者出现T2高信号。在一氧化二氮滥用患者中,运动神经兴奋性测试显示峰值反应降低(7.08±0.87 mV,P = 0.05),潜伏期延长(7.09±0.28 ms,P < 0.01),超兴奋性增加(-32.95±1.74%,P < 0.05),对去极化电流的适应性降低[TEd(40 - 60 ms)56.53±0.70%,P < 0.05];感觉测试仅显示峰值反应降低(30.54±5.98 μV,P < 0.05)。同时,维生素B12缺乏患者的运动测试仅显示对去极化电流的适应性降低[TEd(40 - 60 ms)55.72±1.60%,P < 0.01];感觉测试显示峰值反应降低(25.86±3.44 μV,P < 0.05),超兴奋性增加(-28.58±3.71%,P < 0.001),亚兴奋性增加(8.31±1.64%,P < 0.05),对去极化电流的适应性降低[TEd(峰值)67.31±3.35%,P < 0.001]。与维生素B12缺乏相比,一氧化二氮滥用患者表现出明显的运动超兴奋性变化,而感觉超兴奋性变化不明显,这提示其病理过程不同于维生素B12缺乏。一氧化二氮滥用可能不仅通过阻断蛋氨酸代谢,还通过影响结旁区域的毒性作用导致轴突功能障碍。